Alvotech (ALVO) Receivables - Net (2020 - 2026)
Alvotech (ALVO) posted Receivables - Net of $47.8 million for Q1 2026, down 31.43% on a QoQ basis from $69.7 million in Q4 2025, and down 71.59% year-over-year from $168.3 million in Q1 2025.
Alvotech (ALVO) Receivables - Net (2020 - 2026) Analysis & Trends
Alvotech's Receivables - Net history runs 7 years deep, the most recent figure standing at $47.8 million for Q1 2026.
- Quarterly Receivables - Net fell 71.59% year-over-year to $47.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.8 million (down 71.59% YoY) and the FY2025 annual result came in at $187.4 million, up 16.95% from the prior year.
- Receivables - Net was $47.8 million for Q1 2026 at Alvotech, down from $69.7 million in the prior quarter.
- Across five years, Receivables - Net topped out at $168.3 million in Q1 2025 and bottomed at $5.3 million in Q2 2022.
- A 5-year average of $70.2 million and a median of $58.8 million in 2025 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2024 — Receivables - Net surged 473.5% — and 2026, when it tumbled 71.59%.
- Alvotech's Receivables - Net stood at $28.7 million in 2022, then jumped by 60.7% to $46.0 million in 2023, then jumped by 95.47% to $90.0 million in 2024, then fell by 22.52% to $69.7 million in 2025, then sank by 31.43% to $47.8 million in 2026.
- Business Quant data shows ALVO's Receivables - Net at $47.8 million in Q1 2026, $69.7 million in Q4 2025, and $160.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.82 Mn |
| Mar 31, 2026 | 47.82 Mn |
| Dec 31, 2025 | 69.74 Mn |
| Dec 31, 2025 | 69.74 Mn |
| Sep 30, 2025 | 160.22 Mn |
| Sep 30, 2025 | 160.22 Mn |
| Jun 30, 2025 | 108.10 Mn |
| Jun 30, 2025 | 108.10 Mn |
| Mar 31, 2025 | 168.32 Mn |
| Mar 31, 2025 | 168.32 Mn |
| Dec 31, 2024 | 90.01 Mn |
| Dec 31, 2024 | 90.01 Mn |
| Sep 30, 2024 | 77.42 Mn |
| Sep 30, 2024 | 77.42 Mn |
| Jun 30, 2024 | 93.52 Mn |
| Jun 30, 2024 | 93.52 Mn |
| Mar 31, 2024 | 41.25 Mn |
| Mar 31, 2024 | 41.25 Mn |
| Dec 31, 2023 | 46.05 Mn |
| Dec 31, 2023 | 46.05 Mn |